Sentences with phrase «avian influenza data»
Also this week, a large, international group of researchers is calling for a Global Initiative on Sharing Avian Influenza Data, Capua notes (Science, 25 August).
http://www.sciencemag.org/
Instead, it uses information the CDC posts in the Global Initiative on Sharing Avian Influenza Data (GISAID) database, launched in 2006 by a number of science institutes and universities worldwide (including WHO, the CDC and the Max Planck Institute for Informatics) to encourage data - sharing in response to the global spread of the H5N1 avian flu.
Not exact matches
The agency also pledged to immediately release newly generated flu sequence information from now on — including data on the dangerous H5N1 avian influenza strain, should it arrive in the United States.
CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.
In April 2017, Moderna published human data for its mRNA vaccine technology in Molecular Therapy, which showed that its first prophylactic vaccine candidate, mRNA - 1440 — an mRNA prophylactic vaccine against avian H10N8 influenza — induced high levels of immunogenicity and was safe and well tolerated.
Browse 148 Market Data Tables and 26 Figures spread through 161 Pages and in - depth TOC on «Veterinary / Animal Vaccines Market Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant)- Global Forecast to 2022» https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html Early buyers will receive 10 % customization on reports.
Prepare solicitations and provide technical review (including safety and efficacy data) of proposals for avian influenza, classical swine fever, Rift valley fever, and other vaccines.